Forte Biosciences
FBRX
32 hedge funds and large institutions have $13.3M invested in Forte Biosciences in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.02% more ownership
Funds ownership: 2.08% → 2.09% (+0.02%)
6% less funds holding
Funds holding: 34 → 32 (-2)
14% less capital invested
Capital invested by funds: $15.5M → $13.3M (-$2.22M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$119K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$13.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.76K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.1K |
| 5 |
Renaissance Technologies
New York
|
+$1.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$5.22K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$3K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
-$3K |
| 4 |
LA
LM Advisors
San Diego,
California
|
-$2.08K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$907 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Russell Investments Group
London,
United Kingdom
| $317 | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $176 | – | – | – |
|
|
LWCFA
28
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| $139 | – | – | – |
|
|
RFG
29
REAP Financial Group
Austin,
Texas
| $68 | – | – | – |
|
30
UBS Group
Zurich,
Switzerland
| $23 | -$87 | -5 | -83% |
|
31
JP Morgan Chase
New York
| $12 | – | – | – |
|
32
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | – | – | – |
|
|
CG
33
Cutler Group
San Francisco,
California
| – | -$3K | -159 | Closed |
|
|
LA
34
LM Advisors
San Diego,
California
| – | -$2.08K | -101 | Closed |
|
35
Bank of America
Charlotte,
North Carolina
| – | -$17 | -1 | Closed |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$87 | +5 | New |
|
FBRX Hedge Fund Activity: Q1 2024 in Review
32 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2024, worth a combined $13.3M — down 14% from $15.5M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FBRX and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $119K. The largest seller was BlackRock, cutting an estimated $5.22K.
- 32 institutional investors held Forte Biosciences (FBRX) as of Q1 2024, down from 34 in Q4 2023.
- Funds reported $13.3M of Forte Biosciences stock for Q1 2024, down 14% quarter-over-quarter.
- 2 funds opened new Forte Biosciences positions in Q1 2024 and 4 closed out, a net change of -2 holders.
- The largest Forte Biosciences buyer in Q1 2024 was ADAR1 Capital Management, an estimated $119K added.
- The largest Forte Biosciences seller in Q1 2024 was BlackRock, an estimated $5.22K sold.
Based on aggregated 13F filings for Q1 2024.